Alterations of Fas and Fas-related molecules in patients with silicosis.
about
Fas/FasL pathway-mediated alveolar macrophage apoptosis involved in human silicosisSilica exposure and altered regulation of autoimmunityGenetic variation in the FAS gene and associations with acute lung injury.Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients.Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.Asbestos induces reduction of tumor immunity.Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment.Silicosis and renal disease: insights from a case of IgA nephropathy.Expression of the T cell receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases.Keynote lecture in the 13th Japanese Society of Immunotoxicology (JSIT 2006) : -Pathophysiological Development and Immunotoxicology: what we have found from research related to silica and silicate such as asbestos-.Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners.Changes of cytokine production and cell viability of peripheral blood mononuclear cells from silicosis patients: effect of in vitro treatment with acetylsalicylic acid.Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients.Estimating Counterfactual Risk Under Hypothetical Interventions in the Presence of Competing Events: Crystalline Silica Exposure and Mortality From two Causes of Death.A case of Caplan syndrome in a recently diagnosed patient with silicosis: A case report.
P2860
Q23921015-933CFB30-4DAA-470F-BC3A-3DC89F2E6882Q26995554-FEAE4625-47CD-4F88-991C-1FFDC39F26CDQ30498604-404F34C4-CC0D-4E04-A9CD-FA4C81ED0CF3Q33744358-CC4E9D87-36A0-4899-92E3-7B80EE890FC1Q36725352-FF0E25B1-398B-4406-ACFF-D8CF00C4956BQ37537109-9FCCBB8C-9B64-4119-B704-2876464EC9E9Q37946900-611055F8-B1F3-42E3-B340-CFEA0868D3E8Q38668236-CCA90789-71C7-4DCF-A5AF-17B4C808A030Q38993197-B9F2F0B8-D368-40F8-AA48-74557CA6BD42Q40197116-7735446E-2C30-4946-9230-2FDC28C00BBCQ41787771-327C8963-B687-462D-81D8-B20DDF7F131DQ43186791-BB21775F-A79D-476D-99F0-1D4AF1C151E7Q43234857-806F9311-9FEA-4A28-A8A6-B86F28E21666Q51753199-00E8DDE1-45D1-4386-A758-391400D5890FQ53278377-81A275B4-08EA-48B1-A36A-9EFAA0B05AF4Q55689959-449AB378-7CE8-4396-872E-45133D6DF3FF
P2860
Alterations of Fas and Fas-related molecules in patients with silicosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Alterations of Fas and Fas-related molecules in patients with silicosis.
@ast
Alterations of Fas and Fas-related molecules in patients with silicosis.
@en
type
label
Alterations of Fas and Fas-related molecules in patients with silicosis.
@ast
Alterations of Fas and Fas-related molecules in patients with silicosis.
@en
prefLabel
Alterations of Fas and Fas-related molecules in patients with silicosis.
@ast
Alterations of Fas and Fas-related molecules in patients with silicosis.
@en
P2093
P2860
P1476
Alterations of Fas and Fas-related molecules in patients with silicosis.
@en
P2093
Akiko Takata
Ayako Ueki
Fuminori Hyodoh
Hironobu Katsuyama
Masafumi Tomita
Masayasu Kusaka
Takemi Otsuki
Takumi Kishimoto
Yasumitsu Nishimura
Yoshie Miura
P2860
P304
P356
10.1177/153537020623100506
P577
2006-05-01T00:00:00Z